An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.
about
Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysisAcute tryptophan depletion in humans: a review of theoretical, practical and ethical aspectsEvaluation and differential diagnosis of marked, persistent eosinophiliaEffects and side effects associated with the non-nutritional use of tryptophan by humansL-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromesTryptophan Intake in the US Adult Population Is Not Related to Liver or Kidney Function but Is Associated with Depression and Sleep Outcomes.Use of cyclosporin A in the eosinophilia myalgia syndrome.Environmentally induced autoimmune diseases: potential mechanismsPathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis rats.Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.Melatonin, sleep, aging, and the health protection branch.A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).Supraphysiologic L-tryptophan elicits cytoskeletal and macromolecular permeability alterations in hamster small intestinal epithelium in vitro.Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophanL-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms.Use of laboratory tests for immune biomarkers in environmental health studies concerned with exposure to indoor air pollutantsUse of sequential case-control studies to investigate a community Salmonella outbreak in WalesEnhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic.Acute eosinophilic pneumonia with respiratory failure: a new syndrome?Evaluation and differential diagnosis of marked, persistent eosinophilia.Abnormalities of the coronary arteries, neural structures and conduction system of the heart observed postmortem in the eosinophilia-myalgia syndrome, with a discussion of comparative findings from the toxic oil syndrome.Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndromeUse of tryptophan in combination with other antidepressant treatments: a review.Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: absence of toxicity due to saturating absorption.The Safety and Regulatory Process for Amino Acids in Europe and the United States.The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of l-Tryptophan and l-Citrulline.Head and neck manifestations of eosinophilia-myalgia syndrome.Tryptophan and eosinophilia-myalgia syndrome.Litigation over illness associated with tryptophan is possibleTryptan: no association with eosinophilia-myalgia syndromeIndoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study.Health and safety issues pertaining to genetically modified foods.Eosinophilia-myalgia syndrome.L-tryptophan Induced Eosinophilia-Myalgia Syndrome
P2860
Q21146683-DB6C8844-9AD8-4750-BC9A-9C4C3D50E681Q24629807-E9812D33-90EF-463B-B626-C2D0CC9C4148Q27001673-60A838DD-71E0-4AC1-BCC8-3B425484B2ECQ27007669-7A65CF60-F868-4BC0-B4ED-EB94E517F33BQ28363652-96A29B26-EA2D-4898-B1B8-7AE4380FE71EQ30240134-41FA59FC-87A0-4A65-AB07-5CC73841C5BDQ33565235-D81C4E0C-09DE-45E8-B383-6AFC38534457Q33741188-8A6C1F38-D04D-458E-B07E-0D99C9C85949Q33892462-1CF5FD08-834F-477F-AEF2-822CFB190BA9Q33920531-CB75A3C9-2FC7-49B7-B883-C23EC0726DB2Q33921718-DE2E3361-8C22-4A1D-92C7-4A174DEA1435Q34138191-1CBCEB05-9B1F-4660-94AC-867658A0898EQ34180411-C7C725E7-65D8-48C7-A8D9-4EFB7DDBEF81Q34195164-F9226AF4-2026-4328-ABCA-4468449B9426Q34264077-D3339B0A-65F6-4BFC-988C-1624EF41053AQ35005697-F4237B9E-DDC8-4545-8940-C1EC3058445BQ35035077-05F6199E-BA9D-4F78-911B-76D7370F0E99Q35558251-3838DA82-EA7C-4253-8EBB-80D920A32AD9Q35765540-E027A900-6256-4055-8524-EAF293568C69Q35910797-9A8B2CBF-87EB-4D6C-9BDA-FB0967C7B679Q36176737-8B8C4D37-9DCA-4C55-95F4-9D4DEEF44C32Q36647530-EA6B3656-40D8-4B58-B100-D5E0B321D13AQ36961666-6BE192B3-0C60-4F2B-8462-5C21ECD1D48AQ36986106-5704B906-47C7-4760-BE5A-06398F6D8DDBQ37347671-2C3C80BE-BB8A-4100-AE07-E77703697A99Q39033992-0ECD9691-37C0-4490-AE1B-677D034A2263Q39033996-C780B4B7-4BB5-44AD-A2FC-57F3292B0B23Q40593793-194C985D-C247-4283-A4AA-F6D13F8132DAQ42542394-17305965-0AF4-4C6E-AD4B-86F1C4CA5EE2Q42762013-DA33E697-D2A8-4B44-8344-83E7F7977431Q42762858-402E86FD-F68E-4BBD-A68B-6305D11B3217Q46393442-AE0F7B39-6F82-46FA-8836-A1740E3BE658Q48887047-823E3D15-0FF3-46B4-89B7-60232650C90AQ53995081-73F531A2-7F18-4E42-9A88-A747EA26A720Q55050535-F0EA5095-AF85-4A05-91F0-D5C16CA1C52BQ56094679-C1994D4A-0340-4ADF-A428-B6EF82F587B5
P2860
An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
An investigation of the cause ...... ssociated with tryptophan use.
@ast
An investigation of the cause ...... ssociated with tryptophan use.
@en
An investigation of the cause ...... ssociated with tryptophan use.
@nl
type
label
An investigation of the cause ...... ssociated with tryptophan use.
@ast
An investigation of the cause ...... ssociated with tryptophan use.
@en
An investigation of the cause ...... ssociated with tryptophan use.
@nl
prefLabel
An investigation of the cause ...... ssociated with tryptophan use.
@ast
An investigation of the cause ...... ssociated with tryptophan use.
@en
An investigation of the cause ...... ssociated with tryptophan use.
@nl
P2093
P1476
An investigation of the cause ...... ssociated with tryptophan use.
@en
P2093
Belongia EA
Dunnette SL
Hedberg CW
Loegering DA
MacDonald KL
Osterholm MT
P304
P356
10.1056/NEJM199008093230601
P407
P577
1990-08-01T00:00:00Z